Peripheral Arterial Intervention: Comprehensive Question Analysis
Question 1: Most Common Indication for Peripheral Arterial Intervention
Critical limb ischemia (CLTI) is the most common indication for peripheral arterial intervention, representing the primary driver for revascularization procedures. 1
The 2024 ESC guidelines explicitly state that "for limb salvage in patients with CLTI, revascularization is recommended" and emphasize that "early recognition of CLTI and referral to the vascular team are recommended for limb salvage." 1 This reflects the clinical reality that CLTI represents the most urgent and common indication requiring intervention, as it directly threatens limb viability and patient mortality.
While intermittent claudication is more prevalent as a disease manifestation, the guidelines clearly distinguish that revascularization for claudication requires failure of 3 months of optimal medical therapy (OMT) and supervised exercise therapy first. 2 In contrast, CLTI demands immediate revascularization consideration. Recent registry data confirms this pattern, with CLTI accounting for 58.55% of PAD interventions in real-world practice. 3
Answer: B) Critical limb ischemia
Question 2: Preferred Access Site for Lower Extremity Interventions
The femoral artery is the preferred access site for lower extremity peripheral interventions.
This represents the standard approach for antegrade access to treat infrainguinal disease, providing the most direct route to femoropopliteal and below-the-knee lesions. The femoral approach allows for larger sheath sizes, better device deliverability, and optimal working angles for treating lower extremity PAD.
Answer: A) Femoral artery
Question 3: Drug-Eluting Balloon Purpose
Drug-eluting balloons (DEBs) are primarily intended to prevent restenosis by delivering antiproliferative drugs directly to the vessel wall. 4
The mechanism involves coating balloons with paclitaxel or other antiproliferative agents that penetrate the arterial wall during inflation, inhibiting smooth muscle cell proliferation and neointimal hyperplasia—the primary drivers of restenosis. Recent evidence suggests that lesion preparation procedures (atherectomy, intravascular lithotripsy) may enhance drug penetration by improving vessel compliance, potentially increasing DEB effectiveness. 4
Answer: B) Prevent restenosis
Question 4: Highest Resolution Imaging Modality
Computed tomography angiography (CTA) provides the highest resolution for evaluating peripheral arterial disease before intervention. 1
The 2024 ESC guidelines recommend that "in symptomatic patients with aorto-iliac or multisegmental/complex disease, CTA and/or MRA are recommended as adjuvant imaging techniques for preparation of revascularization procedures." 1 While duplex ultrasound (DUS) is recommended as the first-line imaging method to confirm PAD lesions, CTA offers superior spatial resolution, detailed anatomic visualization of calcification, and comprehensive assessment of multilevel disease necessary for procedural planning.
Answer: C) Computed tomography angiography (CTA)
Question 5: Rutherford Classification Purpose
The Rutherford classification is used to assess the severity of peripheral arterial disease.
This standardized system categorizes PAD from asymptomatic disease (Rutherford 0) through mild-moderate-severe claudication (Rutherford 1-3) to CLTI with rest pain, tissue loss, and gangrene (Rutherford 4-6). The classification directly informs treatment decisions and prognosis, with recent data showing significant associations between Rutherford class and outcomes including amputation risk. 3
Answer: C) Severity of peripheral arterial disease
Question 6: Common Complication of Peripheral Arterial Stenting
Stent fracture is a common complication of peripheral arterial stenting, particularly in the femoropopliteal segment.
The superficial femoral artery experiences significant mechanical stress from hip flexion, knee bending, and muscle contraction, subjecting stents to repetitive compression, torsion, and elongation forces. This mechanical environment makes stent fracture a recognized complication that can lead to restenosis and loss of patency. This differs fundamentally from coronary stenting complications and represents a unique challenge in peripheral intervention.
Answer: B) Stent fracture
Question 7: Antiplatelet Regimen After Femoropopliteal Stenting
Dual antiplatelet therapy (DAPT) for at least 1 month is the recommended antiplatelet regimen after femoropopliteal stent placement. 2
The ACC/AHA guidelines specify that patients with PAD should receive antiplatelet therapy with aspirin or clopidogrel for long-term management. 2 While the guidelines state that "long-term DAPT in patients with PAD is not recommended," 1 short-term DAPT (typically 1 month) after stent placement represents standard practice to prevent acute stent thrombosis during the critical endothelialization period, followed by transition to single antiplatelet therapy.
Answer: C) Dual antiplatelet therapy for at least 1 month
Question 8: Device for Chronic Total Occlusions
Re-entry catheters are specifically designed to treat chronic total occlusions (CTO) in peripheral arteries.
These specialized devices facilitate controlled re-entry into the true lumen after subintimal crossing of CTOs, enabling successful revascularization of complex occlusive disease. Re-entry catheters are essential tools for subintimal angioplasty techniques used to cross long chronic total occlusions. 2
Answer: B) Re-entry catheter
Question 9: Balloon-Mounted Stent Technique
Balloon-mounted stent technique is most appropriate for short, non-calcified lesions.
Balloon-mounted (balloon-expandable) stents provide precise deployment and high radial strength, making them ideal for focal, non-calcified lesions where accurate placement is critical. They are less suitable for heavily calcified lesions (which may prevent adequate expansion) or long lesions (where self-expanding stents offer better conformability and flexibility).
Answer: B) Short, non-calcified lesions
Question 10: "Bailout" Definition
In peripheral intervention, "bailout" refers to an unexpected complication requiring immediate additional treatment.
This term describes unplanned interventions necessitated by procedural complications such as flow-limiting dissections, acute vessel closure, perforation, or distal embolization that require immediate corrective action to salvage the procedure and prevent adverse outcomes.
Answer: B) An unexpected complication requiring immediate additional treatment
Question 11: Contraindication to Peripheral Arterial Angioplasty
Severe peripheral arterial calcification preventing balloon expansion is a contraindication to peripheral arterial angioplasty.
When calcification is so severe that balloon inflation cannot adequately expand the vessel lumen, angioplasty becomes technically futile and potentially dangerous (risking vessel rupture with high-pressure inflation). This represents an absolute technical limitation requiring alternative strategies such as atherectomy, intravascular lithotripsy for lesion preparation, or surgical bypass. 4
Diabetes mellitus, hypertension, and hyperlipidemia are cardiovascular risk factors requiring management but are not contraindications to intervention.
Answer: B) Severe peripheral arterial calcification preventing balloon expansion
Question 12: Primary Goal of Atherectomy
The primary goal of atherectomy in peripheral arteries is to remove atherosclerotic plaque. 4
Atherectomy devices mechanically excise or ablate calcified atherosclerotic material, improving vessel compliance and facilitating subsequent balloon angioplasty with reduced barotrauma. 4 This lesion preparation strategy reduces the need for stent implantation and may enhance drug-coated balloon effectiveness by improving drug penetration into the vessel wall. 4 Recent data shows atherectomy is more frequently utilized in patients with severe disease, greater calcification, and CLTI presentations. 5
Answer: B) Remove atherosclerotic plaque
Question 13: Recommended Follow-up Imaging Interval
After successful peripheral intervention, the recommended follow-up imaging interval is typically 1–3 months.
The 2024 ESC guidelines recommend regular follow-up of PAD patients at least annually, assessing clinical and functional status with DUS assessment as needed. 1 However, the initial post-intervention surveillance typically occurs at 1-3 months to detect early restenosis or technical failures requiring reintervention. For renal artery interventions specifically, the guidelines recommend duplex ultrasound at ≤30 days, 6±1 months, and ≤12±1 months, then annually. 2
Answer: C) 1–3 months
Question 14: Flow-Limiting Dissection Description
Flow-limiting dissection after angioplasty is best described as a tear that reduces lumen size and may require stenting.
This represents an intimal-medial disruption that creates a flap compromising the vessel lumen, reducing antegrade flow, and potentially progressing to acute occlusion. Unlike minor dissections that are hemodynamically insignificant, flow-limiting dissections represent a "bailout" situation requiring immediate treatment—typically provisional stenting to tack down the dissection flap and restore adequate luminal diameter.
Answer: C) A tear that reduces lumen size and may require stenting
Question 15: Distal Embolic Protection Device Indication
The use of distal embolic protection devices during peripheral intervention is most indicated in carotid artery stenting.
Carotid interventions carry the highest risk of clinically significant distal embolization causing stroke, making embolic protection devices standard practice. While embolic protection can be considered in other vascular beds, the neurologic consequences of cerebral embolization during carotid stenting represent the primary indication where these devices demonstrate clear clinical benefit.
Answer: C) Carotid artery stenting
Question 16: Ankle-Brachial Index <0.90 Interpretation
An ankle-brachial index (ABI) value of <0.90 indicates moderate to severe disease.
An ABI <0.90 is the diagnostic threshold for PAD, with values 0.70-0.90 indicating mild-moderate disease and values <0.70 indicating severe disease. The 2024 ESC guidelines recommend measuring toe pressure (TP) or toe-brachial index (TBI) in patients with diabetes or renal failure if resting ABI is normal, as these conditions can cause falsely elevated ABI due to arterial calcification. 1
Answer: C) Moderate to severe disease
Question 17: Intra-arterial Vasospasm Prevention Agent
Nitroglycerin is the pharmacologic agent commonly administered intra-arterially to prevent vasospasm during peripheral interventions.
Nitroglycerin acts as a direct vasodilator, preventing and treating catheter-induced arterial spasm. While verapamil (a calcium channel blocker) also has vasodilatory properties and can be used, nitroglycerin represents the most commonly employed first-line agent for this indication due to its rapid onset, short duration, and favorable safety profile.
Answer: A) Nitroglycerin
Question 18: Subintimal Angioplasty Technique Use
The subintimal angioplasty technique is primarily used for crossing long chronic total occlusions.
This technique involves intentionally creating a dissection plane between the intima and media, advancing through the subintimal space to bypass the occluded segment, then re-entering the true lumen distally using re-entry devices. This approach is particularly valuable for long CTOs where intraluminal crossing is not feasible. 2
Answer: B) Crossing long chronic total occlusions
Question 19: Drug-Eluting Stents in Peripheral Arteries
Drug-eluting stents (DES) release antiproliferative drugs to reduce restenosis. 4
DES are coated with agents (typically paclitaxel, sirolimus, or everolimus) that elute over time to inhibit neointimal hyperplasia and reduce restenosis rates. While initially developed for coronary arteries, DES are now used in peripheral applications, though drug-coated balloons have gained preference in many peripheral territories due to avoiding permanent metallic implants while achieving similar anti-restenotic effects. 4
Answer: B) They release antiproliferative drugs to reduce restenosis
Question 20: "Patency" Definition
In the context of peripheral intervention, "patency" refers to the openness of the treated vessel over time.
Patency is the fundamental measure of procedural success and durability, typically reported as primary patency (continuous vessel openness without reintervention), assisted primary patency (maintained openness with prophylactic reintervention before occlusion), or secondary patency (restored openness after occlusion and reintervention). This represents the most critical outcome measure for peripheral interventions, directly correlating with symptom relief, limb salvage, and quality of life. 6
Answer: B) The openness of the treated vessel over time